Fortis Capital Advisors LLC Sells 1,814 Shares of HealthEquity, Inc. $HQY

Fortis Capital Advisors LLC reduced its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 21.2% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,736 shares of the company’s stock after selling 1,814 shares during the quarter. Fortis Capital Advisors LLC’s holdings in HealthEquity were worth $706,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of HQY. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of HealthEquity by 40.2% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 5,115 shares of the company’s stock valued at $491,000 after purchasing an additional 1,466 shares in the last quarter. Versant Capital Management Inc bought a new position in HealthEquity in the first quarter valued at about $28,000. Rhumbline Advisers lifted its holdings in HealthEquity by 1.0% in the first quarter. Rhumbline Advisers now owns 269,977 shares of the company’s stock valued at $23,858,000 after acquiring an additional 2,689 shares during the period. Hennion & Walsh Asset Management Inc. lifted its holdings in HealthEquity by 40.0% in the first quarter. Hennion & Walsh Asset Management Inc. now owns 3,137 shares of the company’s stock valued at $277,000 after acquiring an additional 897 shares during the period. Finally, Portside Wealth Group LLC bought a new position in HealthEquity in the first quarter valued at about $225,000. 99.55% of the stock is owned by institutional investors.

HealthEquity Stock Performance

Shares of HQY opened at $88.59 on Friday. The company has a quick ratio of 4.23, a current ratio of 4.23 and a debt-to-equity ratio of 0.47. The business has a 50-day simple moving average of $92.15 and a two-hundred day simple moving average of $93.72. The stock has a market cap of $7.63 billion, a price-to-earnings ratio of 53.69, a PEG ratio of 1.29 and a beta of 0.47. HealthEquity, Inc. has a 52 week low of $74.07 and a 52 week high of $116.65.

Insider Transactions at HealthEquity

In related news, EVP Delano Ladd sold 6,000 shares of the stock in a transaction dated Friday, September 19th. The stock was sold at an average price of $94.11, for a total transaction of $564,660.00. Following the completion of the sale, the executive vice president owned 79,456 shares in the company, valued at approximately $7,477,604.16. This trade represents a 7.02% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Michael Henry Fiore sold 1,794 shares of the stock in a transaction dated Monday, July 7th. The stock was sold at an average price of $101.73, for a total value of $182,503.62. Following the sale, the executive vice president owned 53,225 shares of the company’s stock, valued at $5,414,579.25. This represents a 3.26% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.50% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on HQY shares. Wall Street Zen raised HealthEquity from a “hold” rating to a “buy” rating in a report on Friday, June 6th. Weiss Ratings reissued a “hold (c+)” rating on shares of HealthEquity in a report on Saturday, September 27th. JPMorgan Chase & Co. increased their target price on HealthEquity from $125.00 to $126.00 and gave the company an “overweight” rating in a report on Wednesday, September 3rd. Barrington Research reissued an “outperform” rating and issued a $125.00 target price on shares of HealthEquity in a report on Friday, August 29th. Finally, Jefferies Financial Group increased their target price on HealthEquity from $130.00 to $134.00 and gave the company a “buy” rating in a report on Wednesday, September 3rd. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $119.77.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.